B

Biogen

Develops therapies for neurological disorders

Data Generation & Patient Services Lead

Clinical Research OperationsConfirmed live in the last 24 hours
Full-timeBaar, SwitzerlandNo salary listedHybrid

About the Job

Requirements

  • An MD, PhD, PharmD, or another advanced degree in Life Sciences is required.
  • At least 12 years of experience in the pharmaceutical, biotechnology, or healthcare industry.
  • Significant leadership experience in Medical Affairs, Medical Research, Evidence Generation, or a related function.
  • Proven experience developing and executing multinational evidence-generation strategies.
  • Strong knowledge of Medical Affairs research, Health Outcomes Research, and Health Technology Assessment.
  • Strong understanding of healthcare systems, reimbursement, market access, and stakeholder environments across the Intercontinental region.
  • Experience supporting pipeline readiness, launch excellence, and lifecycle management across multiple assets and/or therapeutic areas.
  • Demonstrated success working within global and regional matrix organizations and influencing without formal authority.
  • Strategic thinking, analytical problem-solving, stakeholder engagement, project management, and cross-functional leadership skills.
  • Fluency in English and strong proficiency with Microsoft Office and project management tools.

Responsibilities

  • Drive the BIR data-generation strategy by partnering with Country Medical teams and cross-functional partners to anticipate evidence needs and develop integrated evidence plans supporting value demonstration, HTA/JCA requirements, market access, and regional regulatory expectations.
  • Translate emerging reimbursement, healthcare policy, and stakeholder requirements into evidence-generation, development, and launch strategies.
  • Lead pipeline medical readiness for priority assets and indications from an evidence-generation and patient services perspective, ensuring BIR requirements are incorporated into global development, evidence-generation, and launch strategies.
  • Define and advance the BIR patient services strategy, ensuring programs address clear unmet medical needs and deliver meaningful value across the patient journey.
  • Drive affiliate pipeline readiness, regional collaboration, and capability building through coordinated planning, launch readiness assessments, best-practice sharing, and development of common evidence-generation and patient services solutions across BIR.
  • Establish governance and oversight for regional research investments and evidence-generation programs, ensuring execution excellence, milestone achievement, budget management, and impact measurement.
  • Identify evidence gaps across therapeutic areas and the patient journey and translate them into regional evidence priorities and recommendations for global development and lifecycle management.
  • Build and maintain strategic relationships with Key Opinion Leaders, academic institutions, scientific societies, and research networks to advance scientific leadership and innovation.
  • Provide oversight of BIR Medical strategic priorities and execution across therapeutic areas in Evidence Generation and Patient Services, monitoring progress against objectives and driving alignment across affiliates and cross-functional stakeholders.

About the Company

Biogen

Develops therapies for neurological disorders

Biogen is a global biotechnology company focused on neuroscience. It discovers, develops, and delivers therapies for neurological disorders, such as multiple sclerosis and other neurodegenerative diseases. Its product process starts with research and development to identify potential drugs, followed by clinical testing and regulatory approval, ultimately leading to commercialization and patient treatment. Biogen differentiates itself through a long history (founded in 1978), a deep specialization in neuroscience, and an integrated pipeline that moves ideas from discovery to approved medicines, aiming to create value for shareholders while helping communities. The company’s goal is to advance therapies for neurological diseases to improve patients’ lives and generate sustainable value for stakeholders.

Company size
5,001-10,000
Company stage
IPO
Headquarters
Cambridge, MA
Founded
1978

Recently Posted Jobs

Explore more opportunities at Biogen

See more jobs